Search Results - "Jensen, Tomas Ø."

Readmissions, Postdischarge Mortality, and Sustained Recovery Among Patients Admitted to Hospital With Coronavirus Disease 2019 (COVID-19) by Moestrup, Kasper S, Reekie, Joanne, Zucco, Adrian G, Jensen, Tomas Ø, Jensen, Jens-Ulrik S, Wiese, Lothar, Ostrowski, Sisse R, Niemann, Carsten U, MacPherson, Cameron, Lundgren, Jens, Helleberg, Marie

“…Many interventional in-patient coronavirus disease 2019 (COVID-19) trials assess primary outcomes through day 28 post-randomization. Since a proportion of…”
Get full text

Evaluation of HRP2 and pLDH-based rapid diagnostic tests for malaria and prevalence of pfhrp2/3 deletions in Aweil, South Sudan by Lynch, Emily, Jensen, Tomas O, Assao, Bachir, Chihana, Menard, Turuho, Thadeous, Nyehangane, Dan, Manyok, John B, Pasquale, Harriet, Khim, Nimol, Witkowski, Benoit, Coldiron, Matthew E

“…Abstract Background Rapid diagnostic tests (RDT) for malaria are the primary tool for malaria diagnosis in sub-Saharan Africa but the utility of the most…”
Get full text

A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 by Tølbøll Sørensen, Anne Louise, Rolland, Magalie, Hartmann, Jacob, Harboe, Zitta Barrella, Roed, Casper, Jensen, Tomas Ø., Kolte, Lilian, El Fassi, Daniel, Hillingsø, Jens, Radziwon-Balicka, Aneta, Soyka, Robert Sebastian, Hansen, Klaus, Kirkby, Nikolai, Goetze, Jens P., Gybel-Brask, Mikkel, Leinøe, Eva Birgitte, Hvas, Anne-Mette, Kampmann, Peter, Stensballe, Jakob

“…•We describe a 30-year-old woman who developed thrombocytopenia and multiple thromboses after she received the ChAdOx1 nCoV-19 vaccine.•A maximum 4T HIT score…”
Get full text

Quantifying the incidence of severe-febrile-illness hospital admissions in sub-Saharan Africa by Roddy, Paul, Dalrymple, Ursula, Jensen, Tomas O, Dittrich, Sabine, Rao, V Bhargavi, Pfeffer, Daniel A, Twohig, Katherine A, Roberts, Teri, Bernal, Oscar, Guillen, Ethan

“…Severe-febrile-illness (SFI) is a common cause of morbidity and mortality across sub-Saharan Africa (SSA). The burden of SFI in SSA is currently unknown and…”
Get full text

ACTIV trials: cross-trial lessons learned for master protocol implementation by Keshtkar-Jahromi, Maryam, Adam, Stacey J., Brar, Indira, Chung, Lucy K., Currier, Judith S., Daar, Eric S., Davey, Victoria J., Denning, Eileen T., Gelijns, Annetine C., Higgs, Elizabeth S., Jagannathan, Prasanna, Javan, Arzhang Cyrus, Jensen, Tomas O., Jilg, Nikolaus, Kalomenidis, Ioannis, Kim, Peter, Nayak, Seema U., Newell, Matthew, Taiwo, Babafemi O., Yokum, Tammy, Delph, Yvette

“…Abstract The United States Government (USG) public-private partnership “Accelerating COVID-19 Treatment Interventions and Vaccines” (ACTIV) was launched to…”
Get full text

Neurological Complications in COVID-19 Patients: Can Analysis of Specific Antibodies and Viral RNA in Paired Cerebrospinal Fluid and Serum be Used for Accurate Diagnosis of SARS-CoV-2 Neuroinflammatory Disease? A Case Series by Lauridsen, Karin Holst, Olsen, Kristine Boisen, Lund, Eva Løbner, Jensen, Tomas O, Pedersen, Thomas Ingemann, Harboe, Zitta Barrella, Antsupova, Valeria, Rasmussen, Lasse Dam, Röser, Dennis, Banner, Jytte, Franck, Kristina Træholt, Vorobieva Solholm Jensen, Veronika

“…Background: Neurological complications during and after SARS-CoV-2 infection have been frequently described. The detection of either SARS-CoV-2 RNA or specific…”
Get full text

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study by Søgaard, Ole Schmeltz, Reekie, Joanne, Johansen, Isik Somuncu, Nielsen, Henrik, Benfield, Thomas, Wiese, Lothar, Stærke, Nina Breinholt, Iversen, Kasper, Fogh, Kamille, Bodilsen, Jacob, Iversen, Mette, Knudsen, Lene Surland, Klastrup, Vibeke, Larsen, Fredrikke Dam, Andersen, Sidsel Dahl, Hvidt, Astrid Korning, Andreasen, Signe Rode, Madsen, Lone Wulff, Lindvig, Susan Olaf, Øvrehus, Anne, Ostrowski, Sisse Rye, Abildgaard, Christiane, Matthews, Charlotte, Jensen, Tomas O., Raben, Dorthe, Erikstrup, Christian, Fischer, Thea K., Tolstrup, Martin, Østergaard, Lars, Lundgren, Jens

“…To identify individual characteristics associated with serological COVID-19 vaccine responsiveness and the durability of vaccine-induced antibodies. Adults…”
Get full text

Impact of Baseline Severe Acute Respiratory Syndrome Coronavirus 2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of Coronavirus Disease 19: A Multicentric, Prospective, Cohort Study by Jensen, Tomas O, Harper, Katrina, Gupta, Shaili, Liu, Sean T, Dharan, Nila J, Baker, Jason V, Pett, Sarah L, Shaw-Saliba, Kathryn, Esmail, Aliasgar, Ho, Minh Q, Almasri, Eyad, Dewar, Robin L, Lundgren, Jens, Vock, David M

“…Abstract Background Extrapulmonary complications (EPCs) are common in patients hospitalized for coronavirus disease 2019 (COVID-19), but data on their clinical…”
Get full text

A Role for Antimicrobial Stewardship in Clinical Sepsis Pathways: a Prospective Interventional Study by Burston, John, Adhikari, Suman, Hayen, Andrew, Doolan, Heather, Kelly, Melissa L, Fu, Kathy, Jensen, Tomas O, Konecny, Pamela

“…OBJECTIVE To evaluate the impact of early infectious diseases (ID) antimicrobial stewardship (AMS) intervention on inpatient sepsis antibiotic management…”
Get full text

Continuous monitoring is superior to manual measurements in detecting vital sign deviations in patients with COVID‐19 by Grønbæk, Katja Kjær, Rasmussen, Søren Møller, Langer, Natasha Hemicke, Vincentz, Mette, Oxbøll, Anne‐Britt, Søgaard, Marlene, Awada, Hussein Nasser, Jensen, Tomas O., Jensen, Magnus Thorsten, Sørensen, Helge B. D., Aasvang, Eske Kvanner, Meyhoff, Christian Sylvest

“…Background Patients admitted to the emergency care setting with COVID‐19‐infection can suffer from sudden clinical deterioration, but the extent of deviating…”
Get full text

Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019 by Reilly, Cavan, Mylonakis, Eleftherios, Dewar, Robin, Young, Barnaby, Nordwall, Jacqueline, Bhagani, Sanjay, Chia, Po-ying, Davis, Ruby, Files, Clark, Ginde, Adit A, Hatlen, Timothy, Helleberg, Marie, Hayanga, Awori, Jensen, Tomas O, Jain, Mamta K, Kalomenidis, Ioannis, Kim, Kami, Lallemand, Perrine, Lindegaard, Birgitte, Menon, Anupama, Ognenovska, Katherine, Poulakou, Garyfallia, Thorup Røge, Birgit, Rogers, Angela J, Shaw-Saliba, Katy, Sandkovsky, Uriel, Trautner, Barbara W, Vasudeva, Shikha S, Vekstein, Andrew, Viens, Kimberley, Wyncoll, James, DuChateau, Brian, Zhang, Zhenxing, Wu, Shujiang, Babiker, Abdel G, Davey, Victoria, Gelijns, Annetine, Higgs, Elizabeth, Kan, Virginia, Lundgren, Jens, Matthews, Gail V, Lane, H Cliff

“…Abstract Background Biomarker-guided therapy could improve management of inpatients with coronavirus disease 2019 (COVID-19). Although some results indicate…”
Get full text

Female Genital Schistosomiasis and HIV: Research Urgently Needed to Improve Understanding of the Health Impacts of This Important Coinfection by OʼBrien, Daniel P, Ford, Nathan, Djirmay, Amadou G, Calmy, Alexandra, Vitoria, Marco, Jensen, Tomas O, Christinet, Vanessa

“…Evidence suggests that there are important interactions between HIV and female genital schistosomiasis (FGS) that may have significant effects on individual…”
Get full text

C-reactive protein and procalcitonin use in adults in low- and middle-income countries: a narrative review by Lamrous, Amin, Repetto, Ernestina, Depp, Tim, Jimenez, Carolina, Chua, Arlene C, Kanapathipillai, Rupa, Jensen, Tomas O

“…Abstract Objectives C-reactive protein (CRP) and procalcitonin (PCT) are widely used biomarkers in high-income countries. However, evidence for their use in…”
Get full text

Evaluation of a novel heparin-iloprost-based antithrombotic formulation blood collection tube for clinical usage by Radziwon-Balicka, Aneta, Wiwe, Elias F, Jensen, Tomas Ø, Nielsen, Signe G, Copois, Miljena, Sunde, Niclas, Peytz, Nina C, Al-Mousawi, Dhergam A.A., Hansen, Mie C, Petersen, Jesper F, Nørskov, Anne S, Lendorf, Maria E, Hansen, Young B.L., Hansen, Thomas S, Burkhardt, Melanie A, Hansen, Kristian M, Jensen, Claus A.J.

“…•A novel antithrombotic formulation blood collection tube allows simultaneous analysis of thirty-two blood analytes.•The hematological, biochemical and d-dimer…”
Get full text

Malaria in pregnancy: a call for a safe, efficient, and patient-centred approach to first-trimester treatment by Rao, V Bhargavi, Jensen, Tomas O, Jimenez, B Carolina, Robays, Jo, Lasry, Estrella, Sterk, Esther, de Smet, Martin

Get full text

Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19 by Moestrup, Kasper S, Reekie, Joanne, Zucco, Adrian G, Jensen, Tomas Ø, Jensen, Jens Ulrik S, Wiese, Lothar, Ostrowski, Sisse R, Niemann, Carsten U, MacPherson, Cameron, Lundgren, Jens, Helleberg, Marie

Get full text

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial by Polizzotto, Mark N., Nordwall, Jacqueline, Babiker, Abdel G., Phillips, Andrew, Vock, David M., Eriobu, Nnakelu, Kwaghe, Vivian, Paredes, Roger, Mateu, Lourdes, Ramachandruni, Srikanth, Narang, Rajeev, Jain, Mamta K., Lazarte, Susana M., Baker, Jason V., Frosch, Anne E.P., Poulakou, Garyfallia, Syrigos, Konstantinos N., Arnoczy, Gretchen S., McBride, Natalie A., Robinson, Philip A., Sarafian, Farjad, Bhagani, Sanjay, Taha, Hassan S., Benfield, Thomas, Liu, Sean T.H., Antoniadou, Anastasia, Jensen, Jens Ulrik Stæhr, Kalomenidis, Ioannis, Susilo, Adityo, Hariadi, Prasetyo, Jensen MD, Tomas O., Morales-Rull, Jose Luis, Helleberg, Marie, Meegada, Sreenath, Johansen, Isik S., Canario, Daniel, Fernández-Cruz, Eduardo, Metallidis, Simeon, Shah, Amish, Sakurai, Aki, Koulouris, Nikolaos G., Trotman, Robin, Weintrob, Amy C., Podlekareva, Daria, Hadi, Usman, Lloyd, Kathryn M., Røge, Birgit Thorup, Saito, Sho, Sweerus, Kelly, Malin, Jakob J., Lübbert, Christoph, Muñoz, Jose, Cummings, Matthew J., Losso, Marcelo H., Turner, Dan, Shaw-Saliba, Kathryn, Dewar, Robin, Highbarger, Helene, Lallemand, Perrine, Rehman, Tauseef, Gerry, Norman, Arlinda, Dona, Chang, Christina C., Grund, Birgit, Holbrook, Michael R., Holley, Horace P., Hudson, Fleur, McNay, Laura A., Murray, Daniel D., Pett, Sarah L., Shaughnessy, Megan, Smolskis, Mary C., Touloumi, Giota, Wright, Mary E., Doyle, Mittie K., Popik, Sharon, Hall, Christine, Ramanathan, Roshan, Cao, Huyen, Mondou, Elsa, Willis, Todd, Thakuria, Joseph V., Yel, Leman, Higgs, Elizabeth, Kan, Virginia L., Lundgren, Jens D., Neaton, James D., Lane, H. Clifford

“…Passive immunotherapy using hyperimmune intravenous immunoglobulin (hIVIG) to SARS-CoV-2, derived from recovered donors, is a potential rapidly available,…”
Get full text

Impact of baseline SARS-CoV-2 load in plasma and upper airways on the incidence of acute extrapulmonary complications of COVID-19: a multicentric, prospective, cohort study by Jensen, Tomas O, Harper, Katrina, Gupta, Shaili, Liu, Sean T, Dharan, Nila J, Baker, Jason V, Pett, Sarah L, Shaw-Saliba, Kathryn, Esmail, Aliasgar, Ho, Minh Q, Almasri, Eyad, Dewar, Robin L, Lundgren, Jens, Vock, David M

“…Extrapulmonary complications (EPCs) are common in patients hospitalized for COVID-19, but data on their clinical consequences and association with viral…”
Get full text

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial by Holland, Thomas L., Ginde, Adit A., Paredes, Roger, Murray, Thomas A., Engen, Nicole, Grandits, Greg, Vekstein, Andrew, Ivey, Noel, Mourad, Ahmad, Sandkovsky, Uriel, Gottlieb, Robert L., Berhe, Mezgebe, Jain, Mamta K., Marines-Price, Rubria, Agbor Agbor, Barbine Tchamba, Mateu, Lourdes, España-Cueto, Sergio, Lladós, Gemma, Mylonakis, Eleftherios, Rogers, Ralph, Shehadeh, Fadi, Filbin, Michael R., Hibbert, Kathryn A., Kim, Kami, Tran, Thanh, Morris, Peter E., Cassity, Evan P., Trautner, Barbara, Pandit, Lavannya M., Knowlton, Kirk U., Leither, Lindsay, Matthay, Michael A., Rogers, Angela J., Drake, Wonder, Jones, Beatrice, Poulakou, Garyfallia, Syrigos, Konstantinos N., Fernández-Cruz, Eduardo, Di Natale, Marisa, Almasri, Eyad, Balerdi-Sarasola, Leire, Bhagani, Sanjay R., Boyle, Katherine L., Casey, Jonathan D., Chen, Peter, Douin, David J., Files, D. Clark, Günthard, Huldrych F., Hite, R. Duncan, Hyzy, Robert C., Khan, Akram, Kibirige, Moses, Kidega, Robert, Kimuli, Ivan, Kiweewa, Francis, Jensen, Jens-Ulrik, Leshnower, Bradley G., Lutaakome, Joseph K., Manian, Prasad, Menon, Vidya, Morales-Rull, Jose Luis, O'Mahony, D. Shane, Overcash, J. Scott, Ramachandruni, Srikant, Steingrub, Jay S., Taha, Hassan S., Waters, Michael, Young, Barnaby E., Phillips, Andrew N., Murray, Daniel D., Jensen, Tomas O., Padilla, Maria L., Sahner, David, Shaw-Saliba, Katy, Dewar, Robin L., Teitelbaum, Marc, Natarajan, Ven, Rehman, M. Tauseef, Pett, Sarah, Hudson, Fleur, Touloumi, Giota, Brown, Samuel M., Self, Wesley H., Chang, Christina C., Sánchez, Adriana, Weintrob, Amy C., Hatlen, Timothy, Grund, Birgit, Sharma, Shweta, Reilly, Cavan S., Garbes, Pedro, Esser, Mark T., Templeton, Alison, Babiker, Abdel G., Davey, Victoria J., Gelijns, Annetine C., Higgs, Elizabeth S., Kan, Virginia, Matthews, Gail, Thompson, B. Taylor

“…Tixagevimab-cilgavimab is a neutralising monoclonal antibody combination hypothesised to improve outcomes for patients hospitalised with COVID-19. We aimed to…”
Get full text

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial by Barkauskas, Christina, Mylonakis, Eleftherios, Poulakou, Garyfallia, Young, Barnaby E, Vock, David M, Siegel, Lianne, Engen, Nicole, Grandits, Greg, Mosaly, Nilima R, Vekstein, Andrew M, Rogers, Ralph, Shehadeh, Fadi, Kaczynski, Matthew, Mylona, Evangelia K, Syrigos, Konstantinos N, Rapti, Vasiliki, Lye, David C, Hui, Diong Shiau, Leither, Lindsay, Knowlton, Kirk U, Jain, Mamta K, Marines-Price, Rubria, Osuji, Alice, Overcash, J Scott, Kalomenidis, Ioannis, Barmparessou, Zafeiria, Waters, Michael, Zepeda, Karla, Chen, Peter, Torbati, Sam, Kiweewa, Francis, Sebudde, Nicholus, Almasri, Eyad, Hughes, Alyssa, Bhagani, Sanjay R, Rodger, Alison, Sandkovsky, Uriel, Gottlieb, Robert L, Nnakelu, Eriobu, Trautner, Barbara, Menon, Vidya, Lutaakome, Joseph, Matthay, Michael, Robinson, Philip, Protopapas, Konstantinos, Koulouris, Nikolaos, Kimuli, Ivan, Baduashvili, Amiran, Braun, Dominique L, Günthard, Huldrych F, Ramachandruni, Srikanth, Kidega, Robert, Kim, Kami, Hatlen, Timothy J, Phillips, Andrew N, Murray, Daniel D, Jensen, Tomas O, Padilla, Maria L, Accardi, Evan X, Shaw-Saliba, Katy, Dewar, Robin L, Teitelbaum, Marc, Natarajan, Ven, Laverdure, Sylvain, Highbarger, Helene C, Rehman, M Tauseef, Vogel, Susan, Vallée, David, Crew, Page, Atri, Negin, Schechner, Adam J, Pett, Sarah, Hudson, Fleur, Badrock, Jonathan, Touloumi, Giota, Brown, Samuel M, Self, Wesley H, North, Crystal M, Ginde, Adit A, Chang, Christina C, Kelleher, Anthony, Nagy-Agren, Stephanie, Vasudeva, Shikha, Looney, David, Nguyen, Hien H, Sánchez, Adriana, Weintrob, Amy C, Grund, Birgit, Sharma, Shweta, Reilly, Cavan S, Paredes, Roger, Bednarska, Agnieszka, Gerry, Norman P, Babiker, Abdel G, Davey, Victoria J, Gelijns, Annetine C, Higgs, Elizabeth S, Kan, Virginia, Matthews, Gail, Thompson, B Taylor

“…Ensovibep (MP0420) is a designed ankyrin repeat protein, a novel class of engineered proteins, under investigation as a treatment of SARS-CoV-2 infection. To…”
Get full text